Cyberkinetics
Encyclopedia
Cyberkinetics is an American company. It was cofounded by John Donoghue, Mijail Serruya, and Gerhard Friehs of Brown University
and Nicho Hatsopoulos of the University of Chicago
. The Braingate technology and related Cyberkinetic’s assets are now owned by privately held Braingate, LLC. Their work helped develop early-stage bionics
in the form of implantable electronic devices and now spinoff Cyberkinetics is taking the technology several steps further. The Food and Drug Administration
(FDA) has approved a clinical trial
to implant the BrainGate
technology into five severely disabled patients to determine if they can use the technology to send simple computer commands through channeled thought.
, and others. They say they're three to five years away from putting a product on the market.
According to their latest SEC filing, the Founders of the company resigned from the Board of Directors at the end of October, 2008.
business and related Cyberkinetic’s assets were sold to privately held Braingate, LLC..
Clinical Trials are now being conducted for the Brian Gate 2 Neural Interface System.
Additional information on Brain Gate can be accessed at www.braingate2.org
Update: July 16, 2009
The pilot clinical trial of the BrainGate2 Neural Interface System is registered at ClinicalTrials.gov; details can be viewed at the following location:
www.clinicaltrials.gov/ct2/show/NCT00912041
Brown University
Brown University is a private, Ivy League university located in Providence, Rhode Island, United States. Founded in 1764 prior to American independence from the British Empire as the College in the English Colony of Rhode Island and Providence Plantations early in the reign of King George III ,...
and Nicho Hatsopoulos of the University of Chicago
University of Chicago
The University of Chicago is a private research university in Chicago, Illinois, USA. It was founded by the American Baptist Education Society with a donation from oil magnate and philanthropist John D. Rockefeller and incorporated in 1890...
. The Braingate technology and related Cyberkinetic’s assets are now owned by privately held Braingate, LLC. Their work helped develop early-stage bionics
Bionics
Bionics is the application of biological methods and systems found in nature to the study and design of engineering systems and modern technology.The word bionic was coined by Jack E...
in the form of implantable electronic devices and now spinoff Cyberkinetics is taking the technology several steps further. The Food and Drug Administration
Food and Drug Administration
The Food and Drug Administration is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments...
(FDA) has approved a clinical trial
Clinical trial
Clinical trials are a set of procedures in medical research and drug development that are conducted to allow safety and efficacy data to be collected for health interventions...
to implant the BrainGate
BrainGate
BrainGate is a brain implant system developed by the bio-tech company Cyberkinetics in 2008 in conjunction with the Department of Neuroscience at Brown University. The Braingate technology and related Cyberkinetic’s assets are now owned by privately held Braingate, LLC...
technology into five severely disabled patients to determine if they can use the technology to send simple computer commands through channeled thought.
Funding
Scientists behind the project used $9.3 million in first round funding led by Oxford Bioscience Partners. A 2002 merger with Bionic Technologies, co-founded by Brian Hatt and Richard Normann (the inventor of the Utah Array) added to a tech team armed with intellectual property rights gained from Brown, MITMassachusetts Institute of Technology
The Massachusetts Institute of Technology is a private research university located in Cambridge, Massachusetts. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific and technological education and research.Founded in 1861 in...
, and others. They say they're three to five years away from putting a product on the market.
According to their latest SEC filing, the Founders of the company resigned from the Board of Directors at the end of October, 2008.
Merger & Renaming
In late 2004, Cyberkinetics initiated a reverse merger with a Texas company in order to gain access to the public market. The resulting company was renamed Cyberkinetics Neurotechnology Systems, Inc. and its shares are listed under the symbol CYKN.OB. In 2009, the BrainGateBrainGate
BrainGate is a brain implant system developed by the bio-tech company Cyberkinetics in 2008 in conjunction with the Department of Neuroscience at Brown University. The Braingate technology and related Cyberkinetic’s assets are now owned by privately held Braingate, LLC...
business and related Cyberkinetic’s assets were sold to privately held Braingate, LLC..
Clinical Trials
Update: July 8, 2009Clinical Trials are now being conducted for the Brian Gate 2 Neural Interface System.
Additional information on Brain Gate can be accessed at www.braingate2.org
Update: July 16, 2009
The pilot clinical trial of the BrainGate2 Neural Interface System is registered at ClinicalTrials.gov; details can be viewed at the following location:
www.clinicaltrials.gov/ct2/show/NCT00912041